Agios Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BMV:AGIO * Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
08 Nov 24	SellMex$870,749	T. Washburn	Individual	772	Mex$1,127.91
03 Jun 24	SellMex$1,060,363	T. Washburn	Individual	1,362	Mex$778.53
07 Mar 24	SellMex$685,920	Kaye Foster-Cheek	Individual	1,285	Mex$533.79
06 Mar 24	SellMex$2,544,049	Kaye Foster-Cheek	Individual	4,715	Mex$543.04
05 Mar 24	SellMex$1,027,440	T. Washburn	Individual	1,913	Mex$537.08
20 Feb 24	SellMex$228,907	T. Washburn	Individual	504	Mex$454.18

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of AGIO *?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	857,488	1.4%
Hedge Funds	5,674,466	9.3%
Institutions	54,512,463	89.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 80.25% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.9%	Farallon Capital Management, L.L.C.	5,674,466	Mex$3.9b	0.24%	0.9%
9.83%	The Vanguard Group, Inc.	5,631,321	Mex$3.8b	1.54%	no data
8.75%	BlackRock, Inc.	5,016,260	Mex$3.4b	-0.11%	no data
6.14%	Bellevue Asset Management AG	3,515,150	Mex$2.4b	-5.91%	1.53%
4.23%	T. Rowe Price Group, Inc.	2,423,537	Mex$1.6b	-14.4%	0.01%
3.95%	Armistice Capital LLC	2,264,304	Mex$1.5b	2.59%	1.54%
3.76%	State Street Global Advisors, Inc.	2,152,277	Mex$1.5b	-7.68%	no data
3.51%	Erste Asset Management GmbH	2,009,900	Mex$1.4b	-8.01%	0.52%
2.94%	Macquarie Investment Management Business Trust	1,684,993	Mex$1.1b	-0.34%	0.07%
2.62%	Jefferies Financial Group Inc.,Asset Management Arm	1,500,000	Mex$1.0b	0%	0.43%
2.5%	Citadel Advisors LLC	1,433,676	Mex$976.0m	12,100%	0.04%
2.36%	Geode Capital Management, LLC	1,349,651	Mex$918.8m	-0.58%	no data
2.32%	Dimensional Fund Advisors LP	1,329,065	Mex$904.7m	-14.9%	0.01%
1.87%	BVF Partners L.P.	1,073,755	Mex$730.9m	-9.78%	1.23%
1.82%	Frazier Life Sciences Management, LP	1,044,154	Mex$710.8m	0%	1.37%
1.68%	JP Morgan Asset Management	960,722	Mex$654.0m	-42.1%	no data
1.68%	Fisher Asset Management, LLC	960,661	Mex$654.0m	12.3%	0.01%
1.64%	BNPP Asset Management Holding	942,189	Mex$641.4m	3.87%	0.05%
1.63%	Deutsche Asset & Wealth Management	935,252	Mex$636.7m	39.7%	0.01%
1.6%	ArrowMark Colorado Holdings, LLC	917,420	Mex$624.5m	3.93%	0.39%
1.19%	GW&K Investment Management, LLC	683,463	Mex$465.3m	8.32%	0.18%
1.1%	Marshall Wace LLP	631,628	Mex$430.0m	-50%	0.03%
1.09%	Polar Capital Holdings Plc	627,036	Mex$426.8m	-37.4%	0.07%
1.09%	Caligan Partners, LP	626,280	Mex$426.3m	8.03%	4.56%
1.04%	Northern Trust Global Investments	595,480	Mex$405.4m	0.91%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/19 22:02
End of Day Share Price	2024/11/26 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Agios Pharmaceuticals, Inc. is covered by 29 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Peter Lawson	Barclays
George Farmer	BMO Capital Markets Equity Research
Alec Stranahan	BofA Global Research